低剂量吗啡对COPD睡眠和呼吸困难的影响:一项随机试验
Thomas J Altree1, Alison J Pinczel2, Barbara Toson2
1Flinders Health and Medical Research Institute/Adelaide Institute for Sleep Health, Flinders University, Adelaide, Australia; Respiratory and Sleep Medicine Unit, Queen Elizabeth Hospital, Central Adelaide Local Health Network, Adelaide, Australia.
Chest
|December 15, 2024
概括
低剂量吗啡对COPD患者的睡眠效率或呼吸事件没有影响. 然而,它导致了夜间低通风的增加,这可能是有害的副作用,尽管没有改善呼吸困难.
科学领域:
- 肺部医学 肺部医学
- 睡眠医学 睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低剂量吗啡用于慢性COPD呼吸困难,怀疑睡眠相关机制.
- 在COPD中阿片类药物的安全性是令人担忧的,而吗啡对COPD患者睡眠的影响仍未得到研究.
- 这项研究客观地评估了低剂量吗啡对COPD睡眠的影响.
研究的目的:
- 客观地确定低剂量吗啡对COPD患者睡眠效率和其他睡眠参数的影响.
- 调查吗啡对呼吸困难的影响与睡眠相关的潜在机制.
- 在COPD患者的睡眠期间评估低剂量吗啡的安全性.
主要方法:
- 一个随机的,双重匿名的交叉试验,在19名COPD患者中比较持续释放吗啡 (20 mg/d) 与安慰剂.
- 在实验室进行过夜的多睡眠摄影,以测量睡眠效率作为主要结果.
- 二次结果包括睡眠呼吸障碍,氧化,二氧化碳水平,生物标志物,喘息和驾驶模拟器性能.
主要成果:
- 吗啡和安慰剂之间的睡眠效率 (66% vs 67%) 和睡眠呼吸障碍的频率是相似的.
- 吗啡降低了呼吸频率,但降低了夜间氧气和率 (平均为2%,最低值为5%),并增加了通过皮肤的二氧化碳水平.
- 接受吗啡的42%的参与者满足了夜间低通风标准,而接受安慰剂的21% (P = .02).
结论:
- 稳定状态低剂量的吗啡不会改变COPD患者的睡眠效率,睡眠障碍呼吸频率或第二天的警觉性.
- 吗啡可能会诱导夜间低通风,这可能是COPD患者的潜在有害影响.
- 不良事件,主要是恶心,在吗啡治疗中更频繁.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188
Opioid Analgesics: Morphine and Other Natural Cogeners
192
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
192
Opioid Analgesics: Synthetic and Semisynthetic Opioids
251
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
251
Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Drugs Used in Lower Respiratory Disorders: Overview
362
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
362
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K


